Fierce Pharma
DECEMBER 2, 2024
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent waves of speculation swirling throughout the biopharma industry. | The former FDA Commissioner pointed to the threat of measles if vaccination rates were to decline by 5%.
Rethinking Clinical Trials
DECEMBER 2, 2024
From left to right: Drs. David Wetter, Guilherme Del Fiol, and Ken Kawamoto, principal investigators for LungSMART The NIH Pragmatic Trials Collaboratory is pleased to welcome LungSMART (Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers) to its portfolio of innovative NIH Collaboratory Trials. Lung cancer is the leading cause of cancer-related deaths in the United States, but only 6.5% of eligible individuals were screened for lung cancer in 20
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 2, 2024
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.
XTalks
DECEMBER 2, 2024
The US Food and Drug Administration (FDA) has approved AOP Health’s landiolol injection, marketed as Rapiblyk, for the treatment of atrial fibrillation (Afib) and atrial flutter in critical care settings. These conditions, collectively known as supraventricular tachycardias, involve the heart beating too fast or irregularly, leading to acute complications.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
DECEMBER 2, 2024
At the center of a new licensing deal is an experimental medicine, PTC518, which is currently being tested in a roughly 250-person study that should produce results next year.
Fierce Pharma
DECEMBER 2, 2024
The FDA is investigating reports of patients develo | The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona and is evaluating the need for “further regulatory action,” the U.S. agency said last week. The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 children who received Skysona during clinical trials had developed blood cancer.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 2, 2024
(Ivan Rodriguez Alba/E+/Getty Images) Nearly half of adolescents and three-quarters of adults in the US were classified as being clinically overweight or obese in 2021. The rates have more than doubled compared with 1990.
Bio Pharma Dive
DECEMBER 2, 2024
Next-generation sequencing allows for critical insights into gene therapy products, which can help streamline and accelerate everything from process development and production to regulatory approval.
Pharma Times
DECEMBER 2, 2024
Race to create first oral drug for obesity intensifies
Pharmaceutical Technology
DECEMBER 2, 2024
The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
DECEMBER 2, 2024
Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s treatment for classic galactosemia.
Pharmaceutical Technology
DECEMBER 2, 2024
Fate has announced the retirement of president and CEO Scott Wolchko with Bob Valamehr set to assume the role from 1 January 2025.
Pharma Times
DECEMBER 2, 2024
new SureSeq CLL + CNV V3 panel improves understanding of CLL
Pharmaceutical Technology
DECEMBER 2, 2024
CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.
pharmaphorum
DECEMBER 2, 2024
Novartis has made a return to the Huntington's disease stage by licensing an oral mRNA splicer from PTC Therapeutics for $1 billion upfront
Pharmaceutical Technology
DECEMBER 2, 2024
The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.
pharmaphorum
DECEMBER 2, 2024
Four years after buying US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal.
Pharmaceutical Technology
DECEMBER 2, 2024
The research team at UQ has secured a grant of $344,000 from the National Foundation for Medical Research and Innovation.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
DECEMBER 2, 2024
Bristol-Myers Squibb has become the latest pharma in the US to file a legal challenge to a block on a 340B drug rebate model opposed by HRSA.
Pharmaceutical Commerce
DECEMBER 2, 2024
A total of 140 companies are being placed on the Entity List, in an effort to limit China’s effectiveness in the sector.
pharmaphorum
DECEMBER 2, 2024
Abingworth 'will launch $1.5bn fund for co-developed drugs' Phil.
Pharmaceutical Commerce
DECEMBER 2, 2024
Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
pharmaphorum
DECEMBER 2, 2024
Part Two: Understand the challenges faced by drug manufacturers when navigating the complexities of global market access for rare and complex conditions. Learn how to overcome these obstacles successfully.
Pharmaceutical Commerce
DECEMBER 2, 2024
The latest news for pharma industry insiders.
pharmaphorum
DECEMBER 2, 2024
Four years after buying US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal.
Pharmaceutical Commerce
DECEMBER 2, 2024
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chase Feiger, MD, co-founder, Ostro, outlines the trends he expects to see over the next 10-15 years when it comes to the intersection of AI and life sciences.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
DECEMBER 2, 2024
Alligator eyes sweeping job cuts and pares down its pipeline Phil.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 2, 2024
The Department Related Standing Committee on Chemicals and Fertilisers, recently reconstituted under the chairpersonship of Lok Sabha member Kirti Azad Jha, will be delving into various aspects of the pharmaceutical sector including the price rise of medicines, need for stringent regulatory reforms, among others as the main subjects during its tenure.
pharmaphorum
DECEMBER 2, 2024
Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce.
XTalks
DECEMBER 2, 2024
Grammy-winning artist Lil Jon has joined forces with Exact Sciences in a dynamic campaign to boost awareness about colon cancer screening. Dubbed “Get Low #2,” the initiative reimagines his iconic early 2000s hit to drive a critical message: encouraging the approximately 60 million Americans overdue for colon cancer screening to prioritize their health.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
26 
Let's personalize your content